Achema middle east

Press Releases

SpringWorks and GSK sign clinical trial collaboration agreement

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple...

Velabs Therapeutics Announces 3 Million Series B Financing to Advance its Functional Antibody Screening Programme

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance...

AbbVie Announces US FDA Lifts Partial Clinical Hold on Phase 3 Study of Venetoclax in Patients with Multiple Myeloma Positive for the Genetic Abnormality

AbbVie , a research-based global biopharmaceutical company announced that the U.S. FDA  has lifted the partial clinical hold placed on CANOVA (M13-494), a Phase 3...

Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health. ...

Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study

Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study and the pre-specified pooled safety analyses of the FERWON-NEPHRO and FERWON-IDA studies at the...

Quanticate Expands Presence in North America with New Toronto Office

Quanticate, a leading global data-focused clinical research organisation(CRO), has announced plans to expand its presence in North America with the opening of a new office...

ideaPoint Announces Enhanced Partnering Software and Mobile App at BIO International

Anaqua’s ideaPoint, a leading provider of innovation management solutions, announced the launch of partnering software ideaPoint 5.1 along with Mobile Scout TM v2. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »